(51 minutes 31 seconds)
The free Flash Player is required.
About this lecture
This Grand Rounds was recorded on January 11, 2007 at the University of Utah as
part of the 2007-2008, T.J. Tsagaris Memorial Lectureship awarded to Dr. Bristow.
The recording has been edited for use as part of the GGOL Grand Rounds series. Dr.
Bristow is a pioneer in the development and use of beta-adrenergic blocking agents
for the treatment of chronic heart failure.
This lecture looks at pharmacogenetic targeting of cardiovascular drugs as a treatment
option in heart failure, using as its premise altered gene expression as a leading
cause of heart failure.
Lecture related to
Chapter 7: Pharmacogenetics
Chapter 12: Adrenergic Agonists and
Chapter 28: Pharmacotherapy of Congestive
Chapter 29: Anti-Arrythmic Drugs